tiprankstipranks
Trending News
More News >
Modalis Therapeutics Corporation (JP:4883)
:4883
Japanese Market

Modalis Therapeutics Corporation (4883) Income Statement

Compare
3 Followers

Modalis Therapeutics Corporation Income Statement

Last quarter (Q2 2025), Modalis Therapeutics Corporation's total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q2, Modalis Therapeutics Corporation's net income was ¥-368.24M. See Modalis Therapeutics Corporation’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 0.00¥ 0.00¥ 40.50M¥ 1.10M¥ 342.00M
Gross Profit
¥ 0.00¥ -731.00K¥ -83.17M¥ 1.10M¥ 342.00M
Operating Expenses
¥ 1.34B¥ 2.37B¥ 2.10B¥ 1.24B¥ 740.35M
Depreciation and Amortization
¥ 731.00K¥ 731.00K¥ 123.67M¥ 77.87M¥ 57.59M
EBITDA
¥ -2.15B¥ -2.37B¥ -2.58B¥ -667.55M¥ -381.96M
Operating Income
¥ -1.34B¥ -2.37B¥ -2.06B¥ -1.24B¥ -398.35M
Other Income/Expenses
¥ 20.72M¥ -19.94M¥ -643.84M¥ 494.03M¥ -41.20M
Pretax Income
¥ -1.32B¥ -2.39B¥ -2.71B¥ -745.42M¥ -439.55M
Net Income
¥ -1.32B¥ -2.39B¥ -2.70B¥ -738.96M¥ -448.41M
Per Share Metrics
Basic EPS
¥ -28.57¥ -77.24¥ -92.85¥ -25.70¥ -17.02
Diluted EPS
¥ -28.57¥ -77.24¥ -92.85¥ -25.70¥ -17.02
Weighted Average Shares Outstanding
46.13M 30.97M 29.11M 28.75M 26.35M
Weighted Average Shares Outstanding (Diluted)
46.13M 30.97M 29.11M 28.75M 26.35M
Currency in JPY

Modalis Therapeutics Corporation Earnings and Revenue History